Mitochondrial complex IV deficiency nuclear type 23 is a rare inherited disorder that affects how cells make energy. Early symptoms of mitochondrial complex IV deficiency nuclear type 23 can include low muscle tone, weakness, feeding trouble, delayed development, and sometimes breathing problems or seizures. It may help to know that doctors have studied this condition for decades, but not everyone will have the same experience. Mitochondrial complex IV deficiency nuclear type 23 often starts in infancy or childhood and is usually lifelong, and severe cases can be life-threatening. Treatment focuses on supportive care, such as help with nutrition, breathing, seizures, and physical development, because there is no established cure.
How many people live with Mitochondrial complex iv deficiency nuclear type 23?
Using a widely cited estimate that mitochondrial diseases as a group affect about 1 in 4,300 people, that suggests roughly 1.9 million people worldwide (Schaefer et al., 2008; United Nations, 2024) and about 78,000 people in the United States (Schaefer et al., 2008; U.S. Census Bureau, 2024). Mitochondrial complex IV deficiency nuclear type 23 is only a very small part of that group, and because no published study shows what share it makes up, there is no reliable global or U.S. count for this exact subtype.
Overview
Mitochondrial complex iv deficiency nuclear type 23Symptoms
Mitochondrial complex IV deficiency nuclear type 23 often affects energy-hungry organs. Signs can include weak muscles, poor feeding, delayed development, and low muscle tone in infancy. Some children also have seizures, breathing problems, or trouble gaining weight.
Outlook and prognosis
Mitochondrial complex IV deficiency nuclear type 23 can range from serious early-life disease to milder, later-onset weakness or coordination problems. Outlook depends on which organs are affected, especially the brain, muscles, and breathing, and how quickly supportive care begins.
Causes and risk factors
Mitochondrial complex iv deficiency nuclear type 23 is caused by a disease-causing gene change, usually inherited from both parents, though a new change can happen. Lifestyle or environmental factors do not cause it, but infections, fasting, or other physical stress may worsen symptoms.
Genetic influences
Genetics are central to Mitochondrial complex iv deficiency nuclear type 23. It is caused by changes in a nuclear gene passed through families, though some cases may appear for the first time in one child.
Diagnosis
Mitochondrial complex IV deficiency nuclear type 23 is usually diagnosed from clinical features, such as developmental or muscle-related problems, together with lab tests. Genetic diagnosis of mitochondrial complex IV deficiency nuclear type 23 confirms the condition, and some people also need imaging or muscle studies.
Treatment and drugs
Treatment for Mitochondrial complex IV deficiency nuclear type 23 focuses on supportive care, such as managing seizures, feeding problems, and muscle weakness. Many living with Mitochondrial complex IV deficiency nuclear type 23 also need physical therapy, nutrition support, and regular specialist follow-up.
Symptoms
Many living with mitochondrial complex IV deficiency nuclear type 23 deal with low energy, weak muscles, and delays in skills such as sitting, walking, or talking. Early features of mitochondrial complex IV deficiency nuclear type 23 can include low muscle tone, feeding trouble, and slower-than-expected development. Features vary from person to person and can change over time. Some people are mildly affected, while others have more serious problems involving the brain, breathing, or other organs.
Babies or children may seem floppy, weak, or unusually tired during everyday activity. This can make head control, sitting upright, and steady movement harder.
Skills like rolling, sitting, walking, or talking may come later than expected. With mitochondrial complex IV deficiency nuclear type 23, some children need extra time and therapy support for motor and speech milestones.
Sucking, chewing, or swallowing may be hard, and meals can take much longer than usual. Tiring during feeds can lead to poor weight gain or slower growth.
Some people breathe fast, breathe shallowly, or have more trouble during sleep or infections. In mitochondrial complex IV deficiency nuclear type 23, weakness of the breathing muscles can make illness harder to recover from.
How people usually first notice Mitochondrial complex iv deficiency nuclear type 23?
Mitochondrial complex IV deficiency nuclear type 23 is usually first noticed in infancy or early childhood, when families or doctors see that a baby seems unusually floppy, has trouble feeding, is not gaining skills like head control or sitting as expected, or becomes very tired with everyday activity. In some children, the first signs of mitochondrial complex IV deficiency nuclear type 23 are more urgent, such as breathing problems, seizures, poor growth, or episodes of illness that seem more severe than expected after a minor infection. Because this condition can look different from one child to another, how mitochondrial complex IV deficiency nuclear type 23 is first noticed can vary, but it often begins with a pattern of low energy, muscle weakness, and delayed development that leads to further testing.
Types of Mitochondrial complex iv deficiency nuclear type 23
No distinct types of Mitochondrial complex iv deficiency nuclear type 23 are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medical treatment can meaningfully delay the start of symptoms in mitochondrial complex IV deficiency nuclear type 23; because it is a very rare inherited condition that affects how cells make energy, symptom onset is usually not something people can control. Healthy habits like regular sleep, balanced meals, staying as active as your body comfortably allows, avoiding smoking and heavy alcohol use, and getting infections treated quickly may support overall health, but they have not been proven to prevent this condition or postpone when it begins. There is no well-established preventive medicine for this disorder, but regular care with a specialist may help spot problems early and support you in the best way possible.
What genetics can tell you about symptoms
For people living with mitochondrial complex IV deficiency nuclear type 23, genetics can help explain why symptoms can look so different from one person to another, even within the same family. The exact gene change may influence which parts of the body are affected most, such as the muscles, brain, heart, or liver, and it can also affect how severe symptoms are and whether they begin in infancy, childhood, or later. Even so, genetics does not always predict the full picture, because mitochondrial disorders often vary in ways that a DNA result alone cannot completely forecast.
Causes and risk factors
Most cases of mitochondrial complex IV deficiency nuclear type 23 are caused by a harmful gene change in nuclear DNA that affects how cells make energy. This change is usually inherited from both parents, but in some families it can happen for the first time in a child. The main risk factors for mitochondrial complex IV deficiency nuclear type 23 are a family history of the condition and parents who both carry the same changed gene. Risk can vary widely from person to person. Infections, fasting, poor nutrition, and other physical stresses do not cause the condition, but they can bring symptoms on sooner or make them worse in someone who already has the gene change.
What are the most common causes or risk factors?
Mitochondrial complex IV deficiency nuclear type 23 is usually caused by inherited changes in a gene that helps cells make energy, so the body cannot produce energy as well as it should. It most often happens when a child inherits one nonworking copy of that gene from each parent, so the main risk factors are a family history of the condition, having two carrier parents, or having parents who are related by blood. There are no well-known lifestyle or environmental risk factors for this specific genetic condition.
Environmental and biological risk factors
For mitochondrial complex IV deficiency nuclear type 23, doctors have not identified clear environmental or biological risk factors that reliably make the condition more likely. Doctors often group risks into internal (biological) and external (environmental). In this condition, current evidence does not show consistent links to outside exposures, maternal health conditions, or birth-related events.
No specific exposure, including pollution, heavy metals, radiation, or common chemicals, is known to reliably increase the chance of mitochondrial complex IV deficiency nuclear type 23. Research in very rare conditions is ongoing, but an outside trigger has not been established.
Maternal infections, diabetes, high blood pressure, or medication exposures during pregnancy have not been clearly tied to this condition. In most cases, doctors do not find a pregnancy-related biological factor that explains why it occurred.
Prematurity, low birth weight, or delivery complications are not known causes of mitochondrial complex IV deficiency nuclear type 23. These events may affect a baby's health in other ways, but they are not established risk factors for this condition.
Genetic risk factors
Mitochondrial complex IV deficiency nuclear type 23 is usually linked to harmful changes in a nuclear gene called PET117. When people ask about the genetic causes of mitochondrial complex IV deficiency nuclear type 23, the main known cause is an inherited problem in this gene that disrupts how cells build complex IV, a key part of energy production. Some risk factors are inherited through our genes. The chance of having the condition is highest when a child inherits two nonworking copies of PET117, one from each carrier parent.
PET117 changes: This condition is most often caused by disease-causing changes in the PET117 gene. PET117 helps cells assemble complex IV in mitochondria, so harmful changes can reduce energy production.
Two changed copies: Mitochondrial complex IV deficiency nuclear type 23 usually develops only when both copies of PET117 are not working properly. This inheritance pattern is called autosomal recessive. People with one changed copy are usually carriers rather than affected.
Carrier parents: If both parents carry one changed PET117 copy, each pregnancy has a 1 in 4, or 25%, chance of the child having the condition. The same pregnancy also has a 1 in 2, or 50%, chance of the child being an unaffected carrier.
Family history: A close family history of this condition or an unexplained mitochondrial disorder can raise the chance that the same gene change is present in the family. This is often one of the earliest clues when doctors assess genetic risk.
Related parents: The chance of inheriting two rare PET117 changes is higher when biological parents are related, such as cousins. This does not create the gene change itself, but it makes autosomal recessive conditions more likely.
Lifestyle risk factors
Lifestyle habits do not cause Mitochondrial complex iv deficiency nuclear type 23, but they can influence energy balance, symptom burden, and the risk of complications. Because this condition affects how cells produce energy, daily routines that increase metabolic stress can make weakness, fatigue, or organ-related symptoms harder to manage. In practice, how lifestyle affects Mitochondrial complex iv deficiency nuclear type 23 often comes down to avoiding energy depletion, supporting nutrition, and reducing physical strain during illness or stress.
Overexertion can worsen fatigue, muscle weakness, or exercise intolerance because energy production is already limited. Gentle, individualized activity with rest breaks may help maintain function without triggering crashes.
Skipping meals, prolonged fasting, or inadequate calorie intake can stress metabolism and may aggravate weakness or low energy. Regular meals with enough calories, protein, and fluids can help support more stable day-to-day functioning.
Viral infections, dehydration, and poor recovery habits can sharply increase metabolic demand and may trigger sudden worsening. Prompt hydration, adequate rest, and early medical attention during illness can help reduce complications.
Short or fragmented sleep can worsen daytime fatigue and reduce the body's ability to cope with limited cellular energy. Consistent sleep routines may improve stamina, concentration, and overall symptom management.
Risk prevention
For people living with Mitochondrial complex iv deficiency nuclear type 23, true prevention of the condition itself is usually not possible because it is an inherited genetic disorder. Prevention focuses more on lowering the risk of complications, avoiding stresses that can push the body past its energy limits, and catching problems early. Some may find that symptoms flare during infections, fasting, overheating, or heavy physical strain, so day-to-day routines can make a real difference. Different people need different prevention strategies—there’s no single formula.
If this condition runs in your family, genetic counseling can help clarify recurrence risk before pregnancy or testing decisions. This does not prevent Mitochondrial complex iv deficiency nuclear type 23 in someone who already has it, but it can support informed family planning.
Viral or bacterial illnesses can place extra stress on cells that already struggle to make energy. Staying up to date with routine vaccines, hand hygiene, and early treatment for fever or dehydration may help reduce setbacks.
Long gaps without food can make it harder for the body to meet energy needs and may trigger weakness or other symptoms. Regular meals, sick-day nutrition plans, and prompt medical advice during vomiting can help protect people with Mitochondrial complex iv deficiency nuclear type 23.
Overheating and dehydration can worsen fatigue, muscle symptoms, or neurologic problems in some people. Fluids, cool environments, and pacing activity in hot weather can lower this risk.
Can you prevent Mitochondrial complex iv deficiency nuclear type 23?
No, this condition cannot usually be prevented, because it is a rare inherited genetic condition that happens when a child is born with a gene change that affects how the body's cells make energy. If this condition runs in a family, genetic counseling before pregnancy may help parents understand the chance of it happening again and learn about testing options, but it cannot guarantee prevention.
Transmission
Mitochondrial complex IV deficiency nuclear type 23 is not contagious, so it cannot spread through coughing, touch, food, water, or sexual contact. Instead, it is a genetic condition that is present from birth.
How Mitochondrial complex IV deficiency nuclear type 23 is inherited is usually through changed copies of a gene in the cell nucleus passed down from both parents. In most families, each parent carries one changed copy without being ill, and a child develops the condition only if they inherit both changed copies. A genetics specialist can help explain what this means for future pregnancies and whether other relatives may also be carriers.
When to test your genes
Consider genetic testing if a baby or child has unexplained developmental delay, low muscle tone, seizures, lactic acidosis, or heart, liver, or muscle problems, especially with a family history of mitochondrial disease. Confirming the gene change can guide monitoring, family planning, and sometimes treatment choices.
Diagnosis
Mitochondrial complex IV deficiency nuclear type 23 is usually diagnosed by putting together a child’s or adult’s symptoms, exam findings, and targeted lab and genetic tests. Because this is a genetic condition, doctors often suspect it when there are features suggesting the body’s cells are not making energy normally, such as muscle weakness, low stamina, developmental concerns, seizures, or problems affecting more than one organ. Doctors usually begin with a careful review of symptoms and family history, then use tests to confirm the diagnosis of mitochondrial complex IV deficiency nuclear type 23. Some diagnoses are clear after a single visit, while others take more time.
Doctors look for patterns such as poor growth, low muscle tone, movement or balance problems, developmental delay, seizures, or heart and liver involvement. In a genetic diagnosis of mitochondrial complex IV deficiency nuclear type 23, the combination of symptoms across several body systems can be an important clue.
Lab tests may check lactate, pyruvate, liver enzymes, blood sugar, and other markers that can suggest trouble with energy production. These results are not specific on their own, but they can support the diagnosis and help rule out other conditions.
Imaging findings such as brain MRI changes or signs of heart muscle disease can help show which organs are affected. Depending on symptoms, doctors may also use an echocardiogram or other heart tests to look for related complications.
In some cases, a small sample of muscle is tested to look at how the mitochondria are working. Specialized lab studies may show reduced complex IV enzyme activity, which strongly supports the diagnosis when combined with other findings.
How is Mitochondrial complex iv deficiency nuclear type 23 diagnosed?
Mitochondrial complex IV deficiency, nuclear type 23, is usually diagnosed by putting several clues together: a person’s symptoms and medical history, a doctor’s exam, and tests that show the body’s cells are having trouble making energy. These tests may include blood and urine tests, brain, heart, or muscle checks depending on the symptoms, and sometimes a small muscle sample to look at how well the energy-making parts of cells are working. Genetic testing can then help confirm the diagnosis by finding the gene change linked to this specific type.
Stages of Mitochondrial complex iv deficiency nuclear type 23
Mitochondrial complex iv deficiency nuclear type 23 does not have defined progression stages. That is because it does not usually follow one clear step-by-step pattern over time, and symptoms can vary a lot from one person to another. Often the process begins when you notice changes in daily life, and diagnosis is usually based on symptoms, a physical exam, blood and urine tests, brain or muscle testing in some cases, and genetic testing to confirm the cause. Doctors also monitor how the condition is affecting energy, movement, growth, and organs over time, since the early symptoms of mitochondrial complex iv deficiency nuclear type 23 can look different in different people.
Outlook and prognosis
The outlook for mitochondrial complex IV deficiency nuclear type 23 is highly variable, ranging from severe early-onset disease with rapid neurologic decline to milder forms with slower progression. Prognosis is generally poorest in infants and young children who develop profound hypotonia, seizures, feeding difficulty, lactic acidosis, or respiratory failure, and in these cases early death can occur. People with later onset or less extensive organ involvement may survive much longer, but they often have persistent developmental, muscular, or neurologic disability. Mortality is driven mainly by complications affecting the brain, breathing, and heart, as well as recurrent metabolic decompensation during illness or fasting. Because this is a rare mitochondrial disorder, long-term survival estimates are not well defined, but close multidisciplinary care and prompt treatment of complications can improve quality of life and may help reduce life-threatening crises.
Long-term effects
For many living with mitochondrial complex IV deficiency nuclear type 23, the long-term picture depends a lot on how severely energy production is affected in different organs. Long-term effects vary widely, with some children having major medical needs early in life and others having a slower, more stable course. The early symptoms of mitochondrial complex IV deficiency nuclear type 23 do not always predict exactly how things will look later, because the brain, muscles, heart, breathing, and growth can be affected to different degrees over time.
Many people with mitochondrial complex IV deficiency nuclear type 23 have lasting delays in motor, speech, or learning skills. In more severe cases, these differences can remain significant through childhood and adulthood and may limit independent daily activities.
Ongoing low muscle tone, weakness, and easy fatigue are common long-term features. For many, this can mean delayed walking, trouble with stairs, or reduced stamina during play, school, or work.
Some may develop seizures, abnormal movements, or balance problems that continue over time. Brain-related effects can also include developmental regression in more severe disease, especially after illness or other physical stress.
Poor weight gain and slow growth can remain long-term concerns, particularly in children with feeding difficulties. Some people also have swallowing problems, which can raise the risk of poor nutrition or chest infections from food or liquid going down the wrong way.
How is it to live with Mitochondrial complex iv deficiency nuclear type 23?
Living with mitochondrial complex IV deficiency nuclear type 23 can mean living with a body that makes energy less efficiently, so everyday activities may take much more effort than expected. Many people with this condition have a mix of low muscle tone or weakness, fatigue, feeding problems, developmental delays, or episodes of serious illness, although the severity can vary widely from one person to another.
In daily life, this often means pacing activity carefully, building routines around therapies and medical visits, and watching closely for infections or other stresses that can trigger setbacks. For families and other close supporters, the condition can bring a heavy caregiving role, with extra planning, emotional strain, and frequent coordination of care, but clear medical support and practical accommodations can make day-to-day life safer and more manageable.
Treatment and drugs
Mitochondrial complex IV deficiency nuclear type 23 is usually treated by managing symptoms and supporting the parts of the body most affected, because there is not yet a treatment that fixes the underlying genetic change. Treatment often looks different for each person, but it may include care for muscle weakness, feeding problems, poor growth, seizures, developmental delays, or heart and liver problems, depending on what is present. Some people need physical, occupational, or speech therapy, while others may need nutrition support, seizure medicines, or close follow-up with heart, nerve, and metabolism specialists. Because early symptoms of mitochondrial complex IV deficiency nuclear type 23 can vary a lot, treatment plans are usually individualized and may change over time as needs become clearer.
Can you cure Mitochondrial complex iv deficiency nuclear type 23?
No, there is currently no cure for mitochondrial complex IV deficiency nuclear type 23, a rare inherited condition that makes it hard for the body’s cells to produce enough energy. Treatment does not fix the underlying cause, but it can help manage symptoms and support day-to-day life, such as using medicines for seizures if needed, nutrition or feeding support, physical therapy, and close care from specialists. For many living with this condition, treatment is focused on easing symptoms, preventing complications, and improving quality of life as much as possible.
Non-drug treatment
Day-to-day care for mitochondrial complex IV deficiency nuclear type 23 usually centers on protecting energy, movement, breathing, feeding, and development rather than on a single procedure. Supportive therapies can make everyday tasks safer and help people stay as strong and comfortable as possible. Because this condition can affect people differently, treatment is usually tailored to the symptoms and age of the person living with it. For many families, supportive care for mitochondrial complex IV deficiency nuclear type 23 starts with regular therapy visits and practical changes at home.
Physical therapy can help maintain strength, joint movement, balance, and endurance as much as possible. For many, this can mean working on sitting, standing, walking, or safer transfers to reduce falls and prevent stiffness.
Occupational therapy focuses on daily activities like dressing, bathing, writing, and using the hands. Therapists may also suggest braces, seating supports, or simple equipment that makes everyday tasks easier and less tiring.
Speech and language therapy can help with communication, feeding, and swallowing if these become difficult. If choking, coughing with meals, or slow feeding appears among the early symptoms of mitochondrial complex IV deficiency nuclear type 23, this therapy can be especially important.
Nutrition care aims to prevent weight loss, dehydration, and low energy from poor intake or feeding problems. A dietitian may suggest texture changes, more frequent meals, or tube feeding when eating by mouth is no longer safe or enough.
Your genes may have an impact on how drugs work for you
For people living with mitochondrial complex IV deficiency nuclear type 23, there is not yet clear proof that the underlying genetic change can reliably predict which medicines will work best or cause side effects, so treatment is usually guided by symptoms and close follow-up rather than a gene-based drug plan. Many with this condition are treated for problems such as seizures, muscle weakness, feeding trouble, or heart issues, and the response to these medicines can vary from one person to another. Because this condition affects how cells make energy, doctors often use extra caution with medicines and watch closely for side effects or worsening symptoms.
Pharmacological treatments
Treatment for mitochondrial complex iv deficiency nuclear type 23 is usually individualized, because there is no single proven medicine that corrects the underlying gene-related energy problem. Many living with mitochondrial complex iv deficiency nuclear type 23 are offered a mix of supportive medicines and carefully chosen supplements to ease symptoms, support energy production, and help protect organs such as the brain, heart, or muscles. Not everyone responds to the same medication in the same way.
Coenzyme Q10, also called ubiquinone or ubiquinol, is often used in mitochondrial disorders to support energy production in cells. It does not cure mitochondrial complex iv deficiency nuclear type 23, but some people may notice better stamina or less fatigue. Doctors usually monitor whether it seems to help over time.
Riboflavin vitamin B2 and thiamine vitamin B1 are commonly used because they help enzymes involved in cell energy work more efficiently. In some people, especially those with early symptoms of mitochondrial complex iv deficiency nuclear type 23, they may be tried as part of a broader treatment plan. Benefits can be modest and vary from one person to another.
L-carnitine may be prescribed when blood tests suggest low carnitine levels or when there are concerns about muscle energy use. It can help the body move fatty acids into cells for energy, although it is not clearly helpful for everyone. Dosing may be increased or lowered gradually to improve tolerance.
If seizures occur, treatment often includes anti-seizure drugs such as levetiracetam, lamotrigine, or clobazam. The goal is to control seizures while avoiding medicines that can strain mitochondria or the liver in some patients. Drug choice depends on age, seizure type, and other health problems.
Genetic influences
In mitochondrial complex IV deficiency nuclear type 23, the underlying cause is an inherited change in nuclear DNA, not something brought on by lifestyle or parenting. This subtype is typically passed down in an autosomal recessive pattern, which means a child inherits one altered gene copy from each parent. A carrier means someone has one gene change but usually does not have symptoms, so parents may have no idea they carry it until a child is diagnosed. The gene problem interferes with complex IV, an important step in how mitochondria make energy, which helps explain why high-energy tissues such as the brain, muscles, and heart may be affected. Many families want to know how mitochondrial complex IV deficiency nuclear type 23 is inherited, and that question matters for siblings and future pregnancies. Even within the same family, the condition can look different from one person to another, so genetic testing and genetic counseling can help confirm the diagnosis and clarify recurrence risk.
Is Mitochondrial complex iv deficiency nuclear type 23 genetic?
Genetics are central to Mitochondrial complex iv deficiency nuclear type 23. It is caused by changes in a nuclear gene passed through families, though some cases may appear for the first time in one child.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of being human and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definitive diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people living with mitochondrial complex IV deficiency nuclear type 23, treatment is often tailored to the exact gene change rather than using one standard drug plan for everyone. Genetic testing helps confirm the diagnosis, gives clues about which body systems may need closer follow-up, and can guide decisions about supportive care and which specialists to involve. When medicines are needed for seizures, heart problems, infections, or other complications, doctors may review them carefully because some drugs can place extra stress on mitochondria or may be less suitable in certain inherited mitochondrial disorders. Not every difference in response is genetic, but knowing the gene involved can help your care team weigh benefits and risks, avoid medicines with known mitochondrial toxicity when possible, and decide whether you may be eligible for research studies or future targeted treatments. For many families asking how genetics affect treatment for mitochondrial complex IV deficiency nuclear type 23, the main value is that genetics helps personalize care, even though there is not yet a gene-specific medicine for most people with this condition. Because this disorder is rare and treatment needs can vary widely, medication decisions are usually best made with a metabolic or mitochondrial disease specialist.
Interactions with other conditions
People living with mitochondrial complex IV deficiency nuclear type 23 can be more affected when another illness puts extra stress on the body, especially infections with fever, breathing problems, or conditions that reduce food and fluid intake. During those times, energy production may drop further, so weakness, fatigue, trouble feeding, developmental slowing, or seizures can become more noticeable. Doctors call it a “comorbidity” when two conditions occur together, and in this disorder problems such as epilepsy, heart involvement, liver disease, or lung complications can make day-to-day symptoms harder to manage. Some may also find that common illnesses like the flu or stomach bugs bring out early symptoms of mitochondrial complex IV deficiency nuclear type 23 or trigger a sudden worsening in someone who had been fairly stable. Because several organs can be involved at once, care often needs to be coordinated across neurology, cardiology, nutrition, and primary care so one problem does not unintentionally worsen another. With careful monitoring and prompt treatment of intercurrent illnesses, many people with mitochondrial complex IV deficiency nuclear type 23 can avoid some of the more serious complications.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Mitochondrial complex iv deficiency nuclear type 23?
Other conditions that can look similar include other rare problems that affect how cells make energy, inherited muscle diseases such as some forms of muscular dystrophy, and brain or nerve conditions that can cause weakness, seizures, trouble with movement, or developmental delay. Depending on which symptoms are strongest, doctors may also check for more common causes such as thyroid problems, vitamin shortages, or other inherited metabolic conditions, which are disorders that affect how the body turns food into energy.
History
Families living with mitochondrial complex IV deficiency nuclear type 23 often spend a long time searching for answers, especially when symptoms begin early and do not fit a more familiar diagnosis. This condition came into view gradually, as doctors and researchers learned to connect problems with energy use in the body to changes in the tiny structures inside cells called mitochondria.
Initially understood only through symptoms, later studies helped show that some children and adults with muscle weakness, low energy, developmental concerns, or problems affecting the brain, heart, or liver were part of a broader group of mitochondrial disorders. As testing improved in the late 20th and early 21st centuries, doctors became better at recognizing patterns and separating one form from another. For many, this changed the experience from being told symptoms were unexplained to having a clearer medical name for what was happening.
Mitochondrial complex IV deficiency nuclear type 23 is one of the more specifically described forms identified through this progress. Researchers later confirmed that it has a genetic cause, but that understanding came after years of careful clinical observation, laboratory work, and advances in mitochondrial testing. Today, the history of mitochondrial complex IV deficiency nuclear type 23 helps explain why the early symptoms of mitochondrial complex IV deficiency nuclear type 23 can look different from one person to the next, and why diagnosis has become more accurate over time.